ALECensa 150mg Capsule: Targeting ALK-Positive Lung Cancer with Precision
In the modern era of lung cancer treatment, precision medicine has become the foundation of oncology. Instead of relying solely on toxic chemotherapy, scientists are now focusing on therapies designed to strike at the genetic drivers of cancer. Among these breakthroughs, ALECensa 150mg (Alectinib) has emerged as one of the best ALK inhibitors, offering a … Read more